Status:
UNKNOWN
Ocular Graft Versus Host Disease After Hematopoietic Stem Cell Transplantation in Adults
Lead Sponsor:
Sheba Medical Center
Conditions:
Graft Versus Host Disease
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to evaluate the presence and manifestations of ocular graft versus host disease in adults that had hematopoietic stem cell transplantation in the past 3 years at the sheba...
Eligibility Criteria
Inclusion
- after hematopoietic stem cell transplantation done at sheba medical center Israel
- 3 month have past from transplantation but no more then 3 years
Exclusion
- transplantation done in the last 3 month or more than 3 years have past since
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00912067
Start Date
July 1 2009
Last Update
June 3 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheba Medical Center
Tel Litwinsky, Israel, 52621